Search | Page 2 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Foundation Update - September 2017

    ... leukemia, ibrutinib's approval came after a randomized clinical trial in which almost half the participants treated with the drug ... Council AAMDSIF is pleased to introduce The Research and Education Council -- a new initiative dedicated to increasing ...

    Article last updated 09/12/2017 - 7:14am.

  2. Foundation Update - July 2017

    ... June 17, the AAMDSIF Patient Advisory Council on Clinical Trials (PACCT+) members met in Arlington, Virginia for the second ... clinical trial design and the state of current MDS research. Learn more .   Young Aplastic ...

    Article last updated 10/09/2017 - 2:42pm.

  3. New AML drugs to accelerate genetic testing

    ... AML, MDS and MPN update: Dr David Steensma talks about the clinical implications of important new data sets ... Dr Steensma focused on a number of topics, his review of research in acute myeloid leukemia (AML) is perhaps most relevant because after ...

    Article last updated 09/25/2017 - 9:32am.

  4. Foundation Update - August 2017

    ... accepted at NIH for treatment. John is now part of a research study in which he is the first aplastic anemia patient to be treated ... ongoing story – including the particulars of this clinical trial and his family's support, all as parts of his experience in ...

    Article last updated 09/05/2017 - 10:53am.

  5. Foundation Update - October 2016

    ... specializing in MDS. The event focused primarily on MDS clinical updates, patient registries, transplantation and related bone ... Available Now: ASCO/EHA Research Summary The AAMDSIF 2016 ASCO/EHA Research ... presented at the 2016 meetings of the American Society of Clinical Oncology and the European Hematology Association, both held annually ...

    Article last updated 10/09/2017 - 2:49pm.

  6. Gemtuzumab Receives New FDA Approval for Acute Myeloid Leukemia

    ... initially successful treatment. However, confirmatory clinical trials showed that the drug did not improve survival and was linked ... M.D., Ph.D., an AML specialist at Fred Hutchinson Cancer Research Center in Seattle. “The data for gemtuzumab benefiting at least some ...

    Research Article last updated 10/03/2017 - 12:56pm.

  7. Computational Modeling and Treatment Identification in the Myelodysplastic Syndromes

    ... models serve as clinically relevant MDS cell lines for pre-clinical assays of investigational agents. MDS is an ideal disease for computational modeling and digital drug simulations. Current research is focused on establishing the prediction value of computational ...

    Research Article last updated 09/18/2017 - 9:46am.

  8. Senior citizens underrepresented in clinical trials

    ... Article Link:  Seniors Miss Out On Clinical Trials Article Source:  ... practice. Yet, older adults are often not included in research studies to any significant extent. This is especially true for cancer ...

    Article last updated 06/29/2017 - 10:44am.

  9. Making Progress for Myelodysplastic Syndromes

    ... biggest challenge is finding enough patients to enroll in clinical trials that could help to advance treatment. But the Aplastic ... this by providing patients and patient data to support research. One of its efforts in this area is the MDS Clinical Research ...

    Article last updated 07/26/2017 - 10:25am.

  10. New study on SCT therapy for SAA, MDS patients

    ... The study is being led by Dr Richard W Childs, Clinical Director of the National Heart, Lung, and Blood Institute’s (NDLBI) Division of Intramural Research in the National Institutes of Health (NIH) and Assistant United States ...

    Article last updated 08/22/2017 - 9:41am.